Suppr超能文献

中药诱导的微小RNA在肝细胞癌中的作用:简要综述

Role of MicroRNAs Induced by Chinese Herbal Medicines Against Hepatocellular Carcinoma: A Brief Review.

作者信息

Guo Ge, Zhou Juhua, Yang Xiaogaung, Feng Jiang, Shao Yanxia, Jia Tingting, Huang Qingrong, Li Yanmin, Zhong Yin, Nagarkatti Prakash S, Nagarkatti Mitzi

机构信息

1 Ludong University, Yantai, Shandong, People's Republic of China.

2 Hangzhou Hesti Biotechnology Co, Ltd, Hangzhou, Zhejiang, People's Republic of China.

出版信息

Integr Cancer Ther. 2018 Dec;17(4):1059-1067. doi: 10.1177/1534735418805564. Epub 2018 Oct 20.

Abstract

MicroRNAs (miRNAs) are highly conserved, noncoding small RNAs that regulate gene expression, and consequently several important functions including early embryo development, cell cycle, programmed cell death, cell differentiation, and metabolism. While there are no effective treatments available against hepatocellular carcinoma (HCC), some Chinese herbal medicines have been shown to regulate growth, differentiation, invasion, and metastasis of HCC. Many studies have shown that Chinese herbal medicines regulate the expression of miRNAs and this may be associated with their ability to control the development of HCC. In this article, the effects of Chinese herbal medicines on the expression of miRNAs and their functions in the regulation of HCC have been reviewed and discussed. miRNAs such as miRNA-221 and miRNA-222 mediated by Chinese herbal medicines may be good biomarkers and therapeutic targets for HCC.

摘要

微小RNA(miRNA)是高度保守的非编码小RNA,可调节基因表达,进而调控包括早期胚胎发育、细胞周期、程序性细胞死亡、细胞分化和代谢在内的多种重要功能。虽然目前尚无有效的肝细胞癌(HCC)治疗方法,但一些中草药已被证明可调节HCC的生长、分化、侵袭和转移。许多研究表明,中草药可调节miRNA的表达,这可能与其控制HCC发展的能力有关。本文对中草药对miRNA表达的影响及其在HCC调控中的作用进行了综述和讨论。由中草药介导的miRNA-221和miRNA-222等miRNA可能是HCC的良好生物标志物和治疗靶点。

相似文献

1
Role of MicroRNAs Induced by Chinese Herbal Medicines Against Hepatocellular Carcinoma: A Brief Review.
Integr Cancer Ther. 2018 Dec;17(4):1059-1067. doi: 10.1177/1534735418805564. Epub 2018 Oct 20.
2
miRNA in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Approaches.
Crit Rev Eukaryot Gene Expr. 2017;27(4):355-361. doi: 10.1615/CritRevEukaryotGeneExpr.2017019539.
5
MicroRNAs involved with hepatocellular carcinoma (Review).
Oncol Rep. 2015 Dec;34(6):2811-20. doi: 10.3892/or.2015.4275. Epub 2015 Sep 15.
6
Effects of sorafenib on lung metastasis in rats with hepatocellular carcinoma: the role of microRNAs.
Tumour Biol. 2015 Nov;36(11):8455-63. doi: 10.1007/s13277-015-3565-1. Epub 2015 May 31.
7
Non-coding RNA in drug resistance of hepatocellular carcinoma.
Biosci Rep. 2018 Oct 9;38(5). doi: 10.1042/BSR20180915. Print 2018 Oct 31.
8
Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
World J Gastroenterol. 2018 Jul 7;24(25):2647-2660. doi: 10.3748/wjg.v24.i25.2647.
9
MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
Hepatology. 2013 Feb;57(2):840-7. doi: 10.1002/hep.26095. Epub 2012 Dec 26.
10
Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
World J Gastroenterol. 2015 Sep 14;21(34):9853-62. doi: 10.3748/wjg.v21.i34.9853.

引用本文的文献

本文引用的文献

1
Atheroprotective effects and molecular targets of bioactive compounds from traditional Chinese medicine.
Pharmacol Res. 2018 Sep;135:212-229. doi: 10.1016/j.phrs.2018.07.012. Epub 2018 Aug 11.
2
HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation.
Int J Cancer. 2018 Dec 15;143(12):3120-3130. doi: 10.1002/ijc.31595. Epub 2018 Oct 4.
3
High expression of miR-21 is not a predictor of poor prognosis in all patients with hepatocellular carcinoma.
Mol Clin Oncol. 2018 Jun;8(6):733-739. doi: 10.3892/mco.2018.1603. Epub 2018 Apr 3.
4
Exploring the molecular mechanisms of Traditional Chinese Medicine components using gene expression signatures and connectivity map.
Comput Methods Programs Biomed. 2019 Jun;174:33-40. doi: 10.1016/j.cmpb.2018.04.002. Epub 2018 Apr 4.
5
Effects of miR-155 on proliferation and apoptosis by regulating FoxO3a/BIM in liver cancer cell line HCCLM3.
Eur Rev Med Pharmacol Sci. 2018 Mar;22(5):1277-1285. doi: 10.26355/eurrev_201803_14468.
7
miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells.
Exp Ther Med. 2018 Feb;15(2):1712-1717. doi: 10.3892/etm.2017.5522. Epub 2017 Nov 16.
8
Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide.
Int J Cancer. 2018 Jun 15;142(12):2471-2477. doi: 10.1002/ijc.31280. Epub 2018 Feb 9.
10
EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.
J Exp Clin Cancer Res. 2018 Jan 9;37(1):3. doi: 10.1186/s13046-017-0670-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验